Skip to content

A Prospective, Mono-Centre Study Evaluating OCS-B® Collagen Bone Graft Substitute in Socket Preservation

A Prospective, Mono-Centre Study Evaluating OCS-B® Collagen Bone Graft Substitute in Socket Preservation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00036005
Enrollment
54
Registered
2025-01-24
Start date
2020-07-23
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K08.1

Interventions

Group 1: Socket Preservation with OCS-B Collagen Group 2: Socket Preservation with OCS-B Collagen w/ autologous wound cover (Tissue Punch or PRF membrane) Group 3: Untreated and uncovered socket (Cont

Sponsors

NIBEC Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: • Patient has signed informed consent to participate in the study. • Requiring extraction of a single non-molar tooth with existing adjacent teeth that are to be retained • Teeth with intact alveolar bone walls • The subject must be in good physical and mental condition • The subject is willing and able to comply with all study related procedures (such as exercising oral hygiene and attending all follow-up procedures). • Full-mouth bleeding score (FMBS) lower than 25%. • Full-mouth plaque score (FMPI) lower than 25%. • The subject is suitable for a 2-stage surgical procedure

Exclusion criteria

Exclusion criteria: • Health conditions, which do not permit the surgical (including anesthesia) or restorative procedure. • Multiple adjacent tooth extractions planned will be excluded • Dental implant adjacent to tooth planned for extraction • Mandibular incisor teeth and all molar teeth will be excluded. • Orthodontic tooth movement into the planned extraction site. • Dehiscence of the alveolar bone of more than 3 mm that can be detected pre-operatively using probing or bone sounding, as well as those that can be clinically detected immediately after tooth extraction will be excluded from this study. • Any disorders directly in the planned implant area such as previous tumors, chronic bone disedisease. • Any ongoing application of interfering medication (steroid therapy, bisphosphonate, etc). • Alcohol or drug abuse as noted in subject records or in subject history. • Reason to believe that the treatment might have a negative effect on the subject's overall situation (psychiatric problems), as noted in subject records or history. • Heavy smoking (> 10 cigarettes per day). • Uncontrolled diabetes, i.e. a subject with diagnosed diabetes that has a history of neglecting doctor's recommendations regarding treatment, food and alcohol intake or A1c level above 8% • Poor compliance. • Active periodontal disease involving the residual dentition, and Periodontitis which has led to more than 3 mm of attachment loss. • Mucosal diseases in the areas to be treated. • Pregnant or lactating women at the time of socket preservation procedure.

Design outcomes

Primary

MeasureTime frame
Safety and Performance Evaluation: Evaluation of safety measures via occurrence of (S)AE ((serious) adverse events), DD (device deficiency) and medical device related events Bone gain 6 months after socket preservation procedure for implant placement.

Secondary

MeasureTime frame
1. Implant survival 2. Implant success 3. Overall Bone regeneration 4. Histological analysis prior to implant insertion including percentage of vital bone, residual graft and connective tissue or other non-bone components 5. Soft tissue outcome (Furhauser Pink Esthetic Score, PES). 6. oral health related quality of life assessment 7. Pain (VAS)

Countries

Germany

Contacts

Public ContactShahram Ghanaati

Universtätsklinikum der Goethe Universität Frankfurt/Main, Klinik für Mund-, Kiefer- und Plastische Gesichtschirurgie

study-unit-mkpg@kgu.de+4963100

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026